OPDIVO, as one agent, is indicated with the treatment of adult and pediatric patients 12 several years of age and older with unresectable or metastatic melanoma.Class II: Prospective matched team cohort study in a representative inhabitants with masked final result assessment that satisfies a-d previously mentioned Or possibly a RCT in the agent po